18660578. PHENYL-N-QUINOLINE DERIVATIVES FOR TREATING A RNA VIRUS INFECTION simplified abstract (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE)

PHENYL-N-QUINOLINE DERIVATIVES FOR TREATING A RNA VIRUS INFECTION

Organization Name

CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE

Inventor(s)

Didier Scherrer of Castelnau-le-Lez (FR)

Jamal Tazi of Clapiers (FR)

Florence Mahuteau-betzer of Saint Remy-les- Chevreuse (FR)

Romain Najman of L'Hay-les-Roses (FR)

Julien Santo of Grabels (FR)

Cécile Apolit of Grabels (FR)

PHENYL-N-QUINOLINE DERIVATIVES FOR TREATING A RNA VIRUS INFECTION - A simplified explanation of the abstract

This abstract first appeared for US patent application 18660578 titled 'PHENYL-N-QUINOLINE DERIVATIVES FOR TREATING A RNA VIRUS INFECTION

The patent application pertains to a compound of formula (I) or its pharmaceutically acceptable salt for treating and/or preventing RNA virus infections, specifically those from group IV or V of the Baltimore classification.

• This compound shows potential for use in the treatment and prevention of RNA virus infections.
• Specifically targets RNA viruses from group IV or V of the Baltimore classification.
• The compound can be used in the development of antiviral medications.
• Offers a new approach to combating RNA virus infections.
• Provides a promising avenue for research in antiviral therapeutics.

Potential Applications: The technology can be applied in the pharmaceutical industry for the development of antiviral drugs targeting RNA viruses from group IV or V.

Problems Solved: This technology addresses the need for effective treatments against RNA virus infections, particularly those from group IV or V of the Baltimore classification.

Benefits: The compound offers potential benefits in the treatment and prevention of RNA virus infections, contributing to advancements in antiviral therapy.

Commercial Applications: The technology has commercial potential in the pharmaceutical industry for the development of antiviral medications targeting specific RNA viruses.

Prior Art: Readers can explore existing research on antiviral compounds and treatments for RNA virus infections to understand the background of this technology.

Frequently Updated Research: Stay informed about the latest advancements in antiviral therapies and research related to RNA virus infections to enhance understanding of this technology.

Questions about RNA Virus Infections: 1. What are the common symptoms of RNA virus infections, and how do they differ from other types of viral infections? 2. How do RNA viruses replicate within host cells, and what makes them challenging to treat effectively?

Original Abstract Submitted

A compound of formula (I) or any of its pharmaceutically acceptable salt for use in the treatment and/or prevention of a RNA virus infection, and a RNA virus infection from group IV or V of the Baltimore classification